Search by Drug Name or NDC

    NDC 63824-0551-30 Mucinex Fast-Max Day Time Severe Cold and Mucinex Fast-Max Night Time Cold and Flu Details

    Mucinex Fast-Max Day Time Severe Cold and Mucinex Fast-Max Night Time Cold and Flu

    Mucinex Fast-Max Day Time Severe Cold and Mucinex Fast-Max Night Time Cold and Flu is a KIT in the HUMAN OTC DRUG category. It is labeled and distributed by RB Health (US) LLC. The primary component is .

    Product Information

    NDC 63824-0551
    Product ID 63824-551_eb3cd5fe-9e3f-46ac-b27a-c7bc85b637fe
    Associated GPIs 43998805406320
    GCN Sequence Number 072330
    GCN Sequence Number Description diphenhydram/PE/DM/acetamin/GG TABLET SEQ 5-10-325MG ORAL
    HIC3 B4O
    HIC3 Description NON-OPIOID ANTITUS-1ST ANTIHIST-DECON-ANALG-EXPECT
    GCN 36493
    HICL Sequence Number 036616
    HICL Sequence Number Description DIPHENHYDRAMINE/PHENYLEPHRIN/DEXTROMETHORPH/ACETAMINOPHEN/GG
    Brand/Generic Brand
    Proprietary Name Mucinex Fast-Max Day Time Severe Cold and Mucinex Fast-Max Night Time Cold and Flu
    Proprietary Name Suffix Maximum Strength
    Non-Proprietary Name Acetaminophen, Dextromethorphan Hydrobromide, Diphenhydramine Hydrochloride, Guaifenesin, and Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name RB Health (US) LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2023-12-31

    Package

    NDC 63824-0551-30 (63824055130)

    NDC Package Code 63824-551-30
    Billing NDC 63824055130
    Package 1 KIT in 1 CARTON (63824-551-30) * 10 TABLET, COATED in 1 BLISTER PACK * 10 TABLET, COATED in 1 BLISTER PACK
    Marketing Start Date 2013-05-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 8ce93565-cf00-4a50-a1f4-0c430219bf15 Details

    Revised: 1/2022